VIVE vs. ONCSQ, KLDO, GNCAQ, GNCA, NBRV, HTGMQ, VRAYQ, NUWE, TIVC, and HSDT
Should you be buying Viveve Medical stock or one of its competitors? The main competitors of Viveve Medical include OncoSec Medical (ONCSQ), Kaleido Biosciences (KLDO), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Nabriva Therapeutics (NBRV), HTG Molecular Diagnostics (HTGMQ), ViewRay (VRAYQ), Nuwellis (NUWE), Tivic Health Systems (TIVC), and Helius Medical Technologies (HSDT). These companies are all part of the "medical" sector.
OncoSec Medical (NASDAQ:ONCSQ) and Viveve Medical (NASDAQ:VIVE) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, community ranking, dividends, media sentiment, institutional ownership, profitability, valuation and earnings.
Viveve Medical has higher revenue and earnings than OncoSec Medical.
In the previous week, Viveve Medical's average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score.
OncoSec Medical has a beta of -18.47, indicating that its stock price is 1,947% less volatile than the S&P 500. Comparatively, Viveve Medical has a beta of 0.06, indicating that its stock price is 94% less volatile than the S&P 500.
Viveve Medical received 311 more outperform votes than OncoSec Medical when rated by MarketBeat users.
17.3% of OncoSec Medical shares are held by institutional investors. 1.3% of OncoSec Medical shares are held by insiders. Comparatively, 5.7% of Viveve Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Viveve Medical beats OncoSec Medical on 5 of the 6 factors compared between the two stocks.
Get Viveve Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for VIVE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VIVE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Viveve Medical Competitors List
Related Companies and Tools